Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-7

First 7 Last

Share
Profile

Follow
lexcorp

8,061 Posts.

530

01/11/24

13:11

Post #: 76418769
Share

Originally posted by htae39 ↑

I don't understand how they are spending 12.3m in operating costs (corporate and staff) in a single quarter. That figure is excluding R&D costs.

I understand that preparing for FDA submissions is a long an expensive process, but their costs don't seem to line with other medical technology companies that are at a similar stage.

I know it's a completely different company and comparison, but EMV is also listed on the ASX and are in the medical device space. They are in the hundreds of millions of market cap (slightly lower than AVR but similar enough)

Their administrative and corporate costs are $500,000. So that's 0.5m compared with 4.5m. Their staff costs include R&D staff and they're 1.67m per quarter compared to AVR's 7.8m.

I would assume developing TAVR products to be more expensive (as a whole) compared to developing products/devices to diagnose stroke, but the latter isn't exactly simple or cheap either! It leads to be understood why AVR made the pivot when they never successfully monetised their tissue products properly.

Another comparison (although a drug development company - not as comparable) is the ASX200 listed NEU who had 2.33m Corporate and Administrative costs for the entire first half and turned a profit. That's 1.1m per quarter compared to AVR's 4.5m in similar periods. Even their R&D costs (17m for 2 quarters, or 8.5m per quarter) are lower despite running 3 trials Phase 2 drug trials, and preparing for a third (which is a phase 3) including paying for the manufacturing of the drug, pharmacology studies, animal studies/other pre-clinical activities)...

Expand

Have you been through the head counts for wages and salaries?

AVR Price at posting: $10.30 Sentiment: Buy Disclosure: Held
Upvote

0 Great analysis

Reply

Top Stories

Monday's HotCopper trends: Boss guidance, Botanix quarterly | July 28

Red flags in the market to watch: How to spot trouble before it hits your portfolio

I88

Infini remobilising at Portland Creek after geo specialists line up 12 'priority' targets

Listen: HotCopper Wire Podcast 019 – Dreaming of the 9,000s

BOE

Boss tanks -42% after quietly flagging 'potential challenges' for Honeymoon

First 7 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last $5.04		Change 0.190(3.92%)		Mkt cap ! $78.14M

Open	High	Low	Value	Volume
$4.86	$5.05	$4.86	$20.97K	4.18K

Buyers (Bids)

No.	Vol.	Price($)
2	3265	$4.87

Sellers (Offers)

Price($)	Vol.	No.
$5.02	1861	2

View Market Depth

No.	Vol.	Price($)
2	3265	4.870
1	454	4.860
2	2144	4.850
1	882	4.840
1	209	4.780

Price($)	Vol.	No.
5.020	1861	2
5.040	1818	1
5.050	968	2
5.070	200	1
5.150	1212	1

Last trade - 14.18pm 28/07/2025 (20 minute delay)

AVR (ASX) Chart

Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-7

Monday's HotCopper trends: Boss guidance, Botanix quarterly | July 28

Red flags in the market to watch: How to spot trouble before it hits your portfolio

Infini remobilising at Portland Creek after geo specialists line up 12 'priority' targets

Listen: HotCopper Wire Podcast 019 – Dreaming of the 9,000s

Boss tanks -42% after quietly flagging 'potential challenges' for Honeymoon

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-7

Top Stories

Monday's HotCopper trends: Boss guidance, Botanix quarterly | July 28

Red flags in the market to watch: How to spot trouble before it hits your portfolio

Infini remobilising at Portland Creek after geo specialists line up 12 'priority' targets

Listen: HotCopper Wire Podcast 019 – Dreaming of the 9,000s

Boss tanks -42% after quietly flagging 'potential challenges' for Honeymoon

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News